Dynamic Dashboard

The Global AMR R&D Hub’s Dynamic Dashboard continuously collects and presents information on more than 8 bn USD AMR R&D investments from across the One Health continuum – human, animal, plant and environment. It also presents information on antibacterial products in the clinical development pipeline and incentives for antibiotic R&D.

 

 

The Global AMR R&D Hub – At a Glance

Read our latest studies & policy briefs, and make sure to utilise our Dynamic Dashboard, offering in-depth knowledge on the global AMR R&D landscape.

AMR Snapshots: Edition 4 with Dame Sally Davies

The AMR Snapshots interview series is a quick, but deep dive into the key challenges we are facing in antimicrobial resistance (AMR), exploring the topic from a variety of different perspectives and featuring key leaders in the field. We were honoured to have had the opportunity to inte...

Incentivising the development of new antibacterial treatments: Progress report by the Global AMR R&D Hub and WHO

Following the call to action in December 2021 under the UK’s G7 Presidency, the Global AMR R&D Hub and WHO submitted a joint progress report on actions to incentivise the development of new antibacterial treatments to the G7 Health and Finance ministers. Access the report and read more ...

Funded by:
Federal Ministry of Education and Research
Federal Ministry of Health